Fig. 2: Survival by diagnosis category and cohort.

(a) illustrates survival in the ES cohort (red) and the No-ES cohort (blue). (b) illustrates survival of ES cohort patients who received a diagnosis (blue) and did not receive a diagnosis (red), alongside survival of No-ES cohort patients who received a diagnosis (green) and did not receive a diagnosis (orange). ES exome sequencing. Lines at 28 days and 100 days represent benchmarks for comparisons with other studies.